Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max Healthcare InstituteNSE:MAXHEALTH +0.51%93 3-Year ROIIC % is 7.44 as of Mar. 2026, which is 12% below its 10-year median of 8.46. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,446.14 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 619 Healthcare Providers & Services companies, Max Healthcare Institute ranks better than 57.19% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Max Healthcare Institute's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 7.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Max Healthcare Institute's 3-Year ROIIC % or its related term are showing as below:
NSE:MAXHEALTH's 3-Year ROIIC % is ranked better than 57.19% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.66
vs NSE:MAXHEALTH: 7.44
Max Healthcare Institute (NSE:MAXHEALTH) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Max Healthcare Institute 3-Year ROIIC % Related Terms
Max Healthcare Institute 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAXHEALTH vs HCA, THC, EHC: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's 3-Year ROIIC % falls into.
Max Healthcare Institute 3-Year ROIIC % Calculation
Max Healthcare Institute's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 16160.14272 (Mar. 2026) - 10452.4 (Mar. 2023) )
/
( 161990.1 (Mar. 2026) - 85247.4 (Mar. 2023) )
=
5707.74272
/
76742.7
=
7.44%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Max Healthcare Institute (NSE:MAXHEALTH) has a 3-Year ROIIC % of 7.44 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Max Healthcare Institute and its competitors. This is 12% below median its historical median of 8.46. Over the past decade, Max Healthcare Institute's 3-Year ROIIC % has ranged from 0.49 to 24.03. According to the industry distribution chart, Max Healthcare Institute ranks #265 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 42.8%.
Is Max Healthcare Institute's 3-Year ROIIC % too high?
Max Healthcare Institute's current 3-Year ROIIC % of 7.44 is 12% below median its 10-year median of 8.46. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 24.03. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.66. Max Healthcare Institute's value of 7.44 is 103.3% above this industry median. Based on the distribution chart, Max Healthcare Institute ranks #265 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #265 out of 619 companies for 3-Year ROIIC %. This puts Max Healthcare Institute in the upper half of its industry. The industry median 3-Year ROIIC % is 3.66. Max Healthcare Institute's value of 7.44 is 103.3% above this benchmark. Historically, Max Healthcare Institute's own 3-Year ROIIC % has ranged from 0.49 to 24.03 over the past decade. While the company's 10-year median is 8.46 vs. the industry median of 3.66, Max Healthcare Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.66, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current 3-Year ROIIC % of 7.44 is 103.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Max Healthcare Institute and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current 3-Year ROIIC % is 7.44, which is 12% below median its own 10-year median of 8.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,446.14, compared to a current price of ₹1,014.10 — trading 29.9% below its estimated fair value. The current 3-Year ROIIC % is 7.44, which is 12% below median its 10-year median of 8.46 and 103.3% above the Healthcare Providers & Services industry median of 3.66. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current 3-Year ROIIC % is 7.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,014.10 is trading 29.9% below its estimated GF Value™ of ₹1,446.14.
GuruFocus considers Max Healthcare Institute to be Significantly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
3-Year ROIIC %: 7.44 (12% below median its 10-year median of 8.46)
GF Value™: ₹1,446.14 vs. price of ₹1,014.10 (29.9% below fair value)
Industry Position: 103.3% above the Healthcare Providers & Services median (#265 of 619)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score
Get the complete analysis for NSE:MAXHEALTH
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
